梅花生物(600873.SH):上半年淨利降4.26%至6.36億元
格隆匯 8 月 5日丨梅花生物(600873.SH)披露2020年半年度報告,實現營業收入81.37億元,同比增長16.58%;歸屬於上市公司股東的淨利潤6.36億元,同比下降4.26%;歸屬於上市公司股東的扣除非經常性損益的淨利潤5.6億元,同比下降3.94%;基本每股收益0.20元。
報告期內,公司克服疫情帶來的各種影響,生產、銷售通過標準化的持續推進和執行,產品供應和銷售出貨兩不誤,實現銷售收入81.37億元,同比增長16.58%,歸屬於上市公司股東的淨利潤6.36億元,同比略有下降,與去年下半年相比,環比增長96%。因白城40萬噸賴氨酸產能全部釋放,動物營養氨基酸版塊收入由去年同期的30.22億元增加至41.28億元,在整體營業收入中的佔比由43.30%增加至50.73%,在毛利中的佔比由24.20%增加至44.10%,版塊整體毛利率由上年同期的14.08%增加至20.12%。食品版塊受疫情影響下游餐飲需求恢復緩慢,該板塊整體收入佔比由去年同期的43.07%下降至36.09%,毛利佔比由57.05%下降至38.25%。受益於豐富及多元化的產品組合,報告期內公司毛利率保持穩定,2020年1-6月份公司綜合毛利率23.2%,淨利潤率8.0%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.